This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethypharm, Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Isabelle Decorte
Introduction
Isabelle Decorte is a notable inventor based in Beauvilliers, France. She has made significant strides in the field of pharmaceutical innovations, particularly with her work on orodispersible tablets. Her contributions have the potential to enhance patient compliance and improve medication delivery.
Latest Patents
Isabelle Decorte holds a patent for "Orodispersible tablets obtained by compression molding." This invention provides an orodispersible tablet characterized by a hardness of 30 to 80 N, preferably between 40 to 75 N. The tablet exhibits a brittleness of less than 1%, ideally less than 0.5%, and is designed to disintegrate in the mouth within 60 seconds, with a preference for 40 seconds. The formulation includes an active ingredient in the form of coated microcrystals or microgranules, combined with a mixture of excipients such as diluents, disintegrants, sweeteners, binders, and flavoring agents.
Career Highlights
Isabelle Decorte is currently associated with Ethypharm, Inc., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in developing new formulations that cater to the needs of patients and healthcare providers alike.
Collaborations
Throughout her career, Isabelle has collaborated with esteemed colleagues such as Yann Prevost and Edouard Gendrot. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Isabelle Decorte's contributions to the field of pharmaceuticals, particularly through her patented orodispersible tablets, highlight her innovative spirit and dedication to improving patient care. Her work continues to inspire advancements in medication delivery systems.